CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
CANADA

About Us

Conference

Partner With Us
  • APAC
    • US
    • EUROPE
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    Bioinformatics & Genomics
    BioTech
    Cell and Gene Therapy
    Drug Discovery and Development
    Life Science AI
    Next-Generation Sequencing
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    CDMO
    Cosmetic
    CRO
    Life Science Testing And Compliance
    Supplement Manufacturing
  • Business Services
    Life Science Consulting
    Life Sciences Marketing and Communication
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading
Top Contract Research Organizations in Europe Top CROs in Europe - 2024

Life Sciences Review

CRO

Unlocking The Potential of Next-Generation Sequencing

Unlocking The Potential of Next-Generation Sequencing

Peter René Hesse,

Vice President Head of Genomics Business,

QIAGEN

Clinical Research Solutions

Delivering Clinical Outcomes Inside Complex Health Systems

Dr. Peter Maclennan

CEO

TCR Solutions

Featured Issue
PreviousNext

Featured Categories

Clinical Research Solutions

Cardiovascular Research

#

The Value of New Antibiotics in the Fight Against AMR

Piero Rijli, Corporate Director, Regulatory Activities and Market Access MENARINI Group
#

Elevating CDMO Performance with Strategic Alignment

Stephen Sheehan, Director of External Development and Manufacturing Alkermes [NASDAQ: ALKS]
#

Reading Cardiac Risk Across The Clinical Trial

Barry Balfe, CEO ICON [NASDAQ:ICON]
#

Cardiovascular Research

Integrating Scientific Insight with Cardiovascular Trial Execution

Dr. Ernest Spitzer, CEO and Medical Director Cardialysis
Unlocking The Potential of Next-Generation Sequencing

Unlocking The Potential of Next-Generation Sequencing

Peter René Hesse,, Vice President Head of Genomics Business,

QIAGEN

AnaPath Services: Forging R&D Excellence with Experience

Forging R&D Excellence with Experience

Son Guk Jin, CEO; Paula Mendoza, CEO

AnaPath Services

#

Expediting R&D for Quick Product Market Launch

Silvia Trasciatti, Chief Scientific Officer

Galileo Research

News

Boosting Laboratory Accuracy: How Proficiency Testing Shapes the Future of Life Sciences

Clinical Laboratories Become a Strategic Driver of Modern Healthcare

Hospital-Based Stem Cell Programs Highlight the Access Challenge

Elevating Patient Care: The Impact of AI on Prognostic Testing

Loading...
#

Improving Gut Health through Innovative Technologies

Massimo Marzorati, CEO

#

Pioneering Strategic Solutions in the MedTech Industry

David Novotny, COO, RQM+

#

Cro

Accelerating Global Healthcare Breakthroughs

Simona Rizea Savu, Managing Director, 3S Pharma

#

Cro

Redefining the Academic-Led Clinical Trial Journey from Bench to Bedside

Yvanne Enever, Founder and CEO, PHARMExcel

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review APAC
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review APAC. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://cro-europe.lifesciencesreviewapac.com